Asia-Pacific Pharmaceuticals: Completed a share repurchase of 19.99 million yuan for employee incentives or employee stock ownership.

The announcement from Asia-Pacific Pharmaceuticals states that the company implemented its share repurchase for the first time on August 11, 2026, and the repurchase has been completed. A total of 3,344,500 shares were repurchased, accounting for 0.45% of the total share capital, with a maximum transaction price of 6.03 yuan per share and a minimum transaction price of 5.91 yuan per share, amounting to a total transaction value of 19.998 million yuan. The repurchase aligns with the established plan and will not have a significant impact on the company's operations. The repurchased shares will be kept in a designated account for the purpose of implementing equity incentives or employee stock ownership plans, and if not used within three years, will be legally cancelled.